CBD Life Sciences Inc. (CBDL)

OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Mar 9, 2026, 9:41 AM EST
-75.00%
Market Cap 569.70K
Revenue (ttm) 178.45K
Net Income (ttm) -107.44K
Shares Out 5.70B
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 84
Average Volume 7,456,296
Open 0.0001
Previous Close 0.0001
Day's Range 0.0001 - 0.0001
52-Week Range 0.0001 - 0.0010
Beta 86.64
RSI 38.05
Earnings Date n/a

About CBD Life Sciences

CBD Life Sciences Inc. engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, coffee, wine, skincare line, tablets, and a line of pet products. CBD Life Sciences Inc. formerly known as Optium Cyber Systems, Inc. and Optium Cyber Systems, Inc. changed its name as CBD Life Sciences Inc. in January 2019. The company is based in Scottsdale, Arizona. [Read more]

Sector Healthcare
CEO Lisa Nelson
Employees 5
Stock Exchange OTCMKTS
Ticker Symbol CBDL
Full Company Profile

Financial Performance

In 2023, CBD Life Sciences's revenue was $167,147, an increase of 4.31% compared to the previous year's $160,241. Losses were -$78,574, -90.86% less than in 2022.

Financial Statements

News

There is no news available yet.